Why ClearPath Clinical Research?
What Challenges is Our Industry Facing?
How we treat disease is evolving to be more targeted to mechanisms of actions through the power of precision based medicine.
The days of PK and Safety Samples being the only samples and data types in primary and secondary endpoints are over. Biomarker Samples, and related data, are now being included.
This has resulted in:
-
Increased complexity of the Schedule of Assessments and sample logistics
-
Increased number of 3rd Party Testing Labs
-
Increased data complexity and challenges in reconciliation
-
Challenges in managing Lab Vendors and Clinical Sites
All of this places a larger burden on clinical study teams.
Our Work
Current Initiatives
Therapies
Developing innovative therapies to address unmet medical needs and improve patient outcomes.
Diagnostics
Enhancing diagnostic tools for early and accurate disease detection, leading to better treatment outcomes.
Personalized Medicine
Advancing personalized medicine to tailor treatments based on individual genetic profiles for more effective healthcare.
Gene Editing
Researching and developing a new gene editing technology with the potential to cure genetic diseases.
Client Stories
Client Testimonials
